Measuring progression and regression of coronary atherosclerosis in clinical trials: problems and progress

Interventions that may influence the evolution of coronary atherosclerosis can be evaluated more rapidly and efficiently in clinical trials with angiographic endpoints as opposed to using coronary events as endpoints. Quantitative coronary arteriography provides precise and reproducible measurements of coronary artery dimensions for this purpose. The variability of 2 quantitative systems was assessed in 54 lesions under 4 different conditions:-same film, same frame; -same film, same view; different frame; -same view from different films obtained within one month; and -same view from different films obtained one to 6 months apart. With the Cardiovascular Angiographic Analysis System (CAAS), variability of repeat measurement of minimum diameter, expressed as 1 standard deviation of the mean, increased from 0.088 mm (same frame) to 0.197 mm (films 1 to 6 months apart) as conditions decreased from optimal to those encountered in clinical studies. With the Cardiovascular Measurement System (CMS), 1 standard deviation for repeat measurements of minimum diameter increased from 0.087 mm (same frame) to 0.240 mm (films one to 6 months apart). The differences between the two systems for measurements of minimum diameter were not statistically significant and CMS tracked the arterial edge more meticulously than did CAAS. A change in minimum diameter ≥ 0.4 mm for CAAS or ≥ 0.48 mm for CMS is more than 2 standard deviations of the mid-term variability and therefore represents a true change, either progression or regression, with greater than 95% probability.Quantitative coronary arteriography is an essential tool in clinical trials to assess the effect of an intervention upon the evolution of coronary atherosclerosis. Some of the problems in data analysis related to this methodology are discussed.

[1]  J. J. Gerbrands,et al.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. , 1985, Circulation.

[2]  M J Malloy,et al.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.

[3]  W. Santamore,et al.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.

[4]  S. Ellis,et al.  Optimal detection of the progression of coronary artery disease: comparison of methods suitable for risk factor intervention trials. , 1986, Circulation.

[5]  M. Fisher,et al.  Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. , 1984, Circulation.

[6]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[7]  D. Waters,et al.  Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis. Implications for clinical trials. , 1993, Circulation.

[8]  E. Bolson,et al.  Quantitative Coronary Arteriography: Estimation of Dimensions, Hemodynamic Resistance, and Atheroma Mass of Coronary Artery Lesions Using the Arteriogram and Digital Computation , 1977, Circulation.

[9]  K. Mizuno,et al.  Angioscopic coronary macromorphology in patients with acute coronary disorders , 1991, The Lancet.

[10]  P Théroux,et al.  A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. , 1990, Circulation.

[11]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[12]  P D Esser,et al.  Quantification of relative coronary arterial stenosis by cinevideodensitometric analysis of coronary arteriograms. , 1984, Circulation.

[13]  J. J. Gerbrands,et al.  Coronary Artery Dimensions from Cineangiograms-Methodology and Validation of a Computer-Assisted Analysis Procedure , 1984, IEEE Transactions on Medical Imaging.

[14]  D. Waters,et al.  Quantitative Angiographic Morphology of the Coronary Artery Lesions at Risk of Thrombotic Occlusion , 1992, Circulation.

[15]  W. Roberts,et al.  Coronary artery imaging with intravascular high-frequency ultrasound. , 1990, Circulation.

[16]  M. LeFree,et al.  Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. , 1987, Circulation.

[17]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[18]  J. Deckers,et al.  Retardation of angiographic progression of coronary artery disease by nifedipine , 1990, The Lancet.

[19]  J. Murgo,et al.  Percutaneous angioscopy during coronary angioplasty using a steerable microangioscope. , 1991, Journal of the American College of Cardiology.

[20]  E L Bolson,et al.  Arteriographic assessment of coronary atherosclerosis. Review of current methods, their limitations, and clinical applications. , 1982, Arteriosclerosis.

[21]  C T Lancée,et al.  Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. , 1989, Journal of the American College of Cardiology.

[22]  S. Azen,et al.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.